Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...
A medical expert claims Trump's bruised hand proves he is receiving monthly infusions for possible dementia, linking it to ...
BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Leqembi® (lecanemab), has been included in the "Commercial Insurance Innovative Drug List", recently introduced by ...
Amid health speculations, US President Donald Trump confidently talks about his 'good memory' during the Kennedy Centre ...
Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...
Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...
President Donald Trump’s tiredness, recent MRI and hand bruise suggest he may be taking medication to treat Alzheimer’s ...
In the last few years, progress has been made in the fight against Alzheimer's disease with a class of therapies called anti-amyloid antibodies (anti-Aβ). These monoclonal anti-Aβs are proteins made ...
First Patient Expected to be Dosed Next Week with Intranasal Foralumab PET Scan Shows Presence of Untreated Neuroinflammation ...
OK Magazine on MSN
Donald Trump's health fuels conspiracy theories as congresswoman claims he's taking Alzheimer's drug
Donald Trump’s health is fueling conspiracy theories. South Los Angeles Congresswoman Sydney Kamlager-Dove claimed that Trump ...
An update from BioArctic AB Class B ( ($SE:BIOA.B) ) is now available. BioArctic AB’s partner Eisai announced that Leqembi® has been included in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback